XML 50 R31.htm IDEA: XBRL DOCUMENT v3.19.2
Stockholders' equity (Tables)
12 Months Ended
Jun. 30, 2019
Share-based Payment Arrangement [Abstract]  
Stock Option Activity
A summary of our stock option activity is as follows (in thousands except per share and contractual life amounts):
 
 
Number of
shares
 
Weighted
average
exercise price
per share
 
Weighted
average
remaining
contractual 
life (years)
 
Aggregate
intrinsic value
Options outstanding as of June 30, 2018
 
5,116

 
$
6.48

 
 
 
 
Granted
 
290

 
5.10

 
 
 
 
Exercised
 
(1,477
)
 
5.99

 
 
 
 
Canceled or expired
 
(520
)
 
6.95

 
 
 
 
Options outstanding as of June 30, 2019
 
3,409

 
$
6.49

 
5.53
 
$
5,748

As of June 30, 2019:
 
 
 
 
 
 
 
 
Options vested and expected to vest
 
3,341

 
$
6.52

 
5.47
 
$
5,564

Options exercisable
 
2,703

 
$
6.74

 
4.95
 
$
4,000


Schedule of Share-based Compensation, Restricted Stock Units Award Activity
A summary of our RSU activity is as follows (in thousands except contractual life amounts):
 
 
 
Number of
Shares
 
Weighted
average
remaining
contractual 
life (years)
 
Aggregate
intrinsic value
RSUs outstanding as of June 30, 2018
 
3,068

 
 
 
 
Granted
 
1,195

 
 
 
 
Vested
 
(1,151
)
 
 
 
 
Canceled
 
(475
)
 
 
 
 
RSUs outstanding as of June 30, 2019
 
2,637

 
1.30
 
$
21,097

As of June 30, 2019:
 
 
 
 
 
 
RSUs expected to vest
 
2,276

 
1.18
 
$
18,205


A Summary of Shares Available for Grant Activity
A summary of our shares available for grant activity is as follows (in thousands):
 
 
Number of
Shares
Shares available for grant as of June 30, 2018
 
3,169

Additional shares authorized pursuant to annual increase provisions of 2009 Equity Incentive Plan
 
1,667

Granted
 
(1,485
)
RSUs withheld for taxes in net share settlements
 
367

Canceled
 
994

Shares available for grant as of June 30, 2019
 
4,712


Stock-Based Compensation Expense
The following table summarizes total stock-based compensation expense included in our consolidated statements of operations (in thousands):
 
 
Fiscal Year Ended June 30,
 
 
2019
 
2018
 
2017
Cost of revenue
 
$
108

 
$
145

 
$
130

Research and development
 
4,830

 
5,535

 
5,543

Sales and marketing
 
1,348

 
1,671

 
2,090

General and administrative
 
2,013

 
2,525

 
2,399

Total stock-based compensation expense
 
$
8,299

 
$
9,876

 
$
10,162


Schedule of Stock-based Compensation Expenses
The following table summarizes total stock-based compensation expense recorded for stock options, RSUs and restricted common stock issued to employees and nonemployees (in thousands):
 
 
Fiscal Year Ended June 30,
 
 
2019
 
2018
 
2017
Stock option awards
 
$
1,644

 
$
2,103

 
$
2,384

RSU awards
 
6,655

 
7,773

 
7,778

Total stock-based compensation expense
 
$
8,299

 
$
9,876

 
$
10,162


Assumptions Used to Estimate Weighted Average Fair Value of Options The weighted average assumptions used to value stock options granted and the resulting weighted average grant date fair value per share were as follows:
 
 
Fiscal Year Ended June 30,
 
 
2019
 
2018
 
2017
Expected volatility
 
39
%
 
42
%
 
39
%
Expected term (in years)
 
6.87

 
4.75

 
4.25

Risk-free interest rate
 
2.99
%
 
2.00
%
 
1.32
%
Dividend yield
 

 

 

Weighted average grant date fair value per share
 
$
2.32

 
$
2.14

 
$
1.87


Schedule of Shares Reserved For Future Issuance
Common stock reserved for future issuance as of June 30, 2019 was as follows (in thousands):
 
 
 
Stock options outstanding
 
3,409

RSUs outstanding
 
2,637

Available for future grants
 
4,712

Total common shares reserved for future issuance
 
10,758